|
| Home : Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement |
|
Aug 16
2021 |
Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement |
|
HUDDINGE, Sweden, Aug. 16, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today that Medivir AB ("Medivir" or "the Company") together with the originators of remetinostat, and TetraLogic Pharmaceuticals Corporation and The Leukemia & Lymphoma Society ("the... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/medivir-strengthens-the-business-development-potential-of-remetinostat-through-renegotiated-multi-party-agreement-301355600.html |
| |
|
Related News
|
» PureSoftware continue de rayonner mondialement avec l'ouverture d'un bureau au Kenya, en Afrique
» 7-year-old fatally shot as gun violence rocks 3 major US cities
|
|
|
